Table 6.
Investigations examining the effects of caffeine nasal sprays on exercise and cognitive performance
| Author | Participants | Protocol | Results | 
|---|---|---|---|
| De Pauw et al. 2017 [79] | Healthy males (n = 10) | 
 • Nasal spray 15 mg/mL caffeine • Nasal spray 80 mg/mL glucose • Placebo nasal spray  | 
 *↑ activity of cingulate, insular, and sensory-motor cortices ⬌ stroop task performance  | 
| De Pauw et al. 2017 [80] | Moderately trained males (n = 11) | 
 • Nasal spray 15 mg/mL caffeine • Nasal spray 80 mg/mL glucose • Placebo nasal spray  | 
 ⬌ plasma caffeine levels ⬌ wingate performance ⬌ 30 min cycling TT performance ⬌ stroop task performance  | 
| Laizure et al. 2017 [81] | Healthy adults (n = 17) | 
 • Inspired powder 100 mg/mL caffeine (AeroShot) • Oral solution 100 mg/248 mL caffeine  | 
 ⬌ peak plasma caffeine levels ⬌ bioavailability  | 
mg/mL = milligram per milliliter, TT = time trial, * = significant difference, ⬌ = no improvement/change, ↑ = increased, ↓ = decreased, min = minute